Efficacy of Lenvatinib, a multitargeted tyrosine kinase inhibitor, on laser-induced CNV mouse model of neovascular AMD.
Wei, Xian
Efficacy of Lenvatinib, a multitargeted tyrosine kinase inhibitor, on laser-induced CNV mouse model of neovascular AMD. [electronic resource] - Experimental eye research 03 2018 - 2-11 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1096-0007
10.1016/j.exer.2017.12.009 doi
Administration, Oral
Analysis of Variance
Angiogenesis Inhibitors--pharmacology
Animals
Cell Movement--drug effects
Cell Proliferation--drug effects
Cells, Cultured
Choroidal Neovascularization--drug therapy
Disease Models, Animal
Humans
Mice
Phenylurea Compounds--pharmacology
Protein Kinase Inhibitors--pharmacology
Quinolines--pharmacology
Vascular Endothelial Growth Factor A--metabolism
Wet Macular Degeneration--drug therapy
Efficacy of Lenvatinib, a multitargeted tyrosine kinase inhibitor, on laser-induced CNV mouse model of neovascular AMD. [electronic resource] - Experimental eye research 03 2018 - 2-11 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1096-0007
10.1016/j.exer.2017.12.009 doi
Administration, Oral
Analysis of Variance
Angiogenesis Inhibitors--pharmacology
Animals
Cell Movement--drug effects
Cell Proliferation--drug effects
Cells, Cultured
Choroidal Neovascularization--drug therapy
Disease Models, Animal
Humans
Mice
Phenylurea Compounds--pharmacology
Protein Kinase Inhibitors--pharmacology
Quinolines--pharmacology
Vascular Endothelial Growth Factor A--metabolism
Wet Macular Degeneration--drug therapy